A Randomized, Double Blinded, Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of anti-SARS-CoV-2 Convalescent Plasma in Hospitalized Patients (CONTAIN COVID-19)
Authors/Creators
- 1. Division of Infectious Disease, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
- 2. Division of Infectious Disease, Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA
- 3. Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA
- 4. Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
Description
This dataset contains de-identified patient data of 941 patients from 21 centers across the United States who were enrolled in the CONTAIN COVID-19 randomized controlled trial that ran from 4/17/2020-3/15/2021. The information in this dataset was used to conduct the analysis reported in the CONTAIN COVID-19 manuscript published in JAMA Internal Medicine (doi: 10.1001/jamainternmed.2021.6850) and includes demographic information, baseline history, baseline medications, baseline laboratory values, clinical status based on the WHO 11-point scale at 14 and 28 days after randomization, antibody titers, randomization arms.
Files
Restricted
The record is publicly accessible, but files are restricted to users with access.
Request access
If you would like to request access to these files, please fill out the form below.
You need to satisfy these conditions in order for this request to be accepted:
To access the data for the CONTAIN COVID-19 Study, please complete the following information and submit the request to CONTAINData@nyulangone.org. Please know that all approved requests will be required to sign a Data Sharing Agreement with NYU Langone Health prior to the receipt of data.
1. Name of requesting investigator(s)
2. Email of requesting investigator
3. Please describe the reason for data request, and intended project description.
4. Suggested deadline if time sensitive. Requests have an average of 2-4 week turnaround.
You are currently not logged in. Do you have an account? Log in here
Additional details
References
- Ortigoza MB, Yoon H, Goldfeld KS, et al. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial [published online ahead of print, 2021 Dec 13]. JAMA Intern Med. 2021;e216850. doi:10.1001/jamainternmed.2021.6850